CN106432392A - Preparation method of ginsenoside Rg1 and ginsenoside Re - Google Patents

Preparation method of ginsenoside Rg1 and ginsenoside Re Download PDF

Info

Publication number
CN106432392A
CN106432392A CN201610792895.6A CN201610792895A CN106432392A CN 106432392 A CN106432392 A CN 106432392A CN 201610792895 A CN201610792895 A CN 201610792895A CN 106432392 A CN106432392 A CN 106432392A
Authority
CN
China
Prior art keywords
ginsenoside
preparation
eluent
conducted
elution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610792895.6A
Other languages
Chinese (zh)
Inventor
黄炳昌
殷金龙
李雪
殷金玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JILIN ZIXIN PHARMACEUTICAL CO Ltd
Original Assignee
JILIN ZIXIN PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JILIN ZIXIN PHARMACEUTICAL CO Ltd filed Critical JILIN ZIXIN PHARMACEUTICAL CO Ltd
Priority to CN201610792895.6A priority Critical patent/CN106432392A/en
Publication of CN106432392A publication Critical patent/CN106432392A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005Glycosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention relates to a preparation method of ginsenoside Rg1 and ginsenoside Re, and belongs to the technical field of medicine. The preparation method comprises the steps that 1 g of total saponins of panax ginseng are taken to be dissolved into a 20% acetonitrile solution, the obtained mixture is taken as a sample, and gradient eluting is conducted through a preparative high performance liquid chromatograph, wherein SinoChrom ODS-BP with the specification of 200 mm*20 mm and 10 micrometers is taken as a chromatographic column, the detection wavelength is 203 nm, the flow speed is 15 ml/min, and the sample feeding amount is 5 ml; eluent of ginsenoside Rg1 and eluent of ginsenoside Re are collected separately, pressure reduction is conducted on the eluents at the low temperature of 50 DEG C or below for recycling acetonitrile, then vacuum concentration is conducted at the high temperature of 60 DEG C to 80 DEG C, vacuum freeze drying is conducted on concentrated liquid, and then freeze-dried powder is prepared. The preparation method has the advantages that the production cost is reduced, environmental friendliness is achieved, the production period is short, the purity of obtained ginsenoside monomers is 90% or above and reaches the purity of a reference substance for content determination, and the yield can reach 80% or above and is much higher than that of a traditional preparation method.

Description

A kind of preparation method of ginsenoside Rg_1 and Re
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of system simultaneously obtaining high-purity ginsenoside monomer Rg1 and Re Preparation Method.
Background technology
Ginseng is famous and precious tonic herb, has and reinforces vital energy, and multiple arteries and veins takes off admittedly, reinforces the spleen to benefit the lung, promotes the production of body fluid and nourish blood, intelligence development of calming the nerves Effect.Its active ingredient is mainly ginsenoside, and current isolated ginsenoside is more than 30 kinds.Ginsenoside Rg1 and Re has it to cardiovascular system, immune system, neural protection and obvious antitumor action.Because of ginsenoside list Body belongs to natural drug, has curative effect high, and the advantages such as toxic and side effect is little, development and application has a extensive future.
Prepared by present separation using Flavonoids by Macroporous Adsorption Resin to carry out ginsenoside monomer more, but, the method uses big The organic solvents such as the chloroform of amount, acetone, methyl alcohol, n-butanol, and be difficult to reclaim, big for environment pollution, and the production cycle is long, substantially In even several months several weeks, additionally, complex manufacturing, complex operation, mechanization, automaticity are low, it is difficult to realize industrialization Big production, the ginsenoside monomer purity produced is low, and substantially below 90%, yield is not high, how below 60%.
Content of the invention
The present invention provides the preparation method of a kind of ginsenoside Rg_1 and Re, to solve the ginsenoside Rg1 producing at present Low with Re monomer purity, the not high problem of yield.
The technical solution used in the present invention is, step is as follows:
Take general ginsenoside or ginseng stem and leave general saponin 1g is dissolved in 20% acetonitrile solution, as sample, use preparative high Effect liquid phase chromatogram instrument, with SinoChrom ODS-BP 200mm × 20mm 10 μm as chromatographic column, detects wavelength 203nm, flow velocity 15ml/min, sample size 5ml;Carry out gradient elution by table 1,
Table 1 gradient elution table
Collecting ginsenoside Rg1, the eluent of Re respectively, eluent first low-temperature reduced-pressure below 50 DEG C reclaims acetonitrile, after 60-80 DEG C of high-temperature pressure-reduction concentrates, and concentrate vacuum freeze drying prepares freeze-dried powder.
Described ginseng stem and leave general saponin is:Take gen-seng haulms, be cut into 1-2cm section, add boiling water twice, 2 hours for the first time, 1.5 hours for the second time, decoction liquor filtered, merging filtrate, and by D101 type large pore resin absorption column, water elution is extremely colourless, then uses 60% ethanol elution, collects 60% ethanol eluate, surveys the clear cream that relative density is 1.06-1.08 when filtrate is concentrated into 80 DEG C, Dry, pulverize, to obtain final product.
Described general ginsenoside is:Taking ginseng, being cut into sheet, add boiling water twice, 2 hours for the first time, 1.5 is little for the second time When, decoction liquor filters, merging filtrate, and by D101 type large pore resin absorption column, water elution is extremely colourless, then is washed by 60% ethanol De-, collect 60% ethanol eluate, survey the clear cream that relative density is 1.06-1.08 when filtrate is concentrated into 80 DEG C, dry, pulverize, Obtain.
Advantages of the present invention is as follows:
1st, economy, environmental protection:Use acetonitrile and water as solvent, and acetonitrile had been carried out time before eluent vacuum freeze-drying Receive, can be recycled after dehydration, greatly reduce production cost, both economically and environmentally beneficial.
2nd, production technology is simple, with short production cycle:Only need a preparative high performance liquid chromatography instrument just can realize people Ginseng soap efficiently separating with Rg1 and Re, disengaging time within 50min, whole separation cycle within 100min, eluent warp After recycling design, use a vacuum freeze drier, i.e. can get highly purified ginsenoside monomer.
3rd, yield is high, purity is big:The ginsenoside monomer purity obtaining, more than 90%, has reached assay comparison The purity of product, yield can reach more than 80%, far above traditional preparation method.
Detailed description of the invention
General ginsenoside used by the present invention or ginseng stem and leave general saponin can be obtained by purchase, or make as follows Standby:
Ginseng stem and leave general saponin is prepared as:Take gen-seng haulms, be cut into 1-2cm section, add boiling water twice, 2 hours for the first time, 1.5 hours for the second time, decoction liquor filtered, merging filtrate, and by D101 type large pore resin absorption column, water elution is extremely colourless, then uses 60% ethanol elution, collects 60% ethanol eluate, surveys the clear cream that relative density is 1.06-1.08 when filtrate is concentrated into 80 DEG C, Dry, pulverize, to obtain final product.
General ginsenoside is prepared as:Taking ginseng, being cut into sheet, add boiling water twice, 2 hours for the first time, 1.5 is little for the second time When, decoction liquor filters, merging filtrate, and by D101 type large pore resin absorption column, water elution is extremely colourless, then is washed by 60% ethanol De-, collect 60% ethanol eluate, survey the clear cream that relative density is 1.06-1.08 when filtrate is concentrated into 80 DEG C, dry, pulverize, Obtain.
Embodiment 1
Take general ginsenoside 1g and be dissolved in 20% acetonitrile solution, as sample, use preparative high performance liquid chromatography instrument, with SinoChrom ODS-BP 200mm × 20mm 10 μm is chromatographic column, detects wavelength 203nm, flow velocity 15ml/min, sample size 5ml;Carry out gradient elution by table 2,
Table 2 gradient elution table
Collecting ginsenoside Rg1, the eluent of Re respectively, eluent first reclaims acetonitriles at 50 DEG C of low-temperature reduced-pressures, latter 60 DEG C High-temperature pressure-reduction concentrates, and concentrate vacuum freeze drying prepares freeze-dried powder.
Embodiment 2
Take general ginsenoside 1g and be dissolved in 20% acetonitrile solution, as sample, use preparative high performance liquid chromatography instrument, with SinoChrom ODS-BP 200mm × 20mm 10 μm is chromatographic column, detects wavelength 203nm, flow velocity 15ml/min, sample size 5ml;Carry out gradient elution by table 3,
Table 3 gradient elution table
Collecting ginsenoside Rg1, the eluent of Re respectively, eluent first reclaims acetonitriles at 40 DEG C of low-temperature reduced-pressures, latter 70 DEG C High-temperature pressure-reduction concentrates, and concentrate vacuum freeze drying prepares freeze-dried powder.
Embodiment 3
Take general ginsenoside 1g and be dissolved in 20% acetonitrile solution, as sample, use preparative high performance liquid chromatography instrument, with SinoChrom ODS-BP 200mm × 20mm 10 μm is chromatographic column, detects wavelength 203nm, flow velocity 15ml/min, sample size 5ml;Carry out gradient elution by table 4,
Table 4 gradient elution table
Collecting ginsenoside Rg1, the eluent of Re respectively, eluent first low-temperature reduced-pressure below 25 DEG C reclaims acetonitrile, after 80 DEG C of high-temperature pressure-reductions concentrate, and concentrate vacuum freeze drying prepares freeze-dried powder.
Use method ibid each embodiment that ginseng stem and leave general saponin is prepared.

Claims (3)

1. the preparation method of a ginsenoside Rg_1 and Re, it is characterised in that step is as follows:Take general ginsenoside or gen-seng haulms Total saposins 1g is dissolved in 20% acetonitrile solution, as sample, uses preparative high performance liquid chromatography instrument, with SinoChrom ODS-BP 200mm × 20mm 10 μm is chromatographic column, detects wavelength 203nm, flow velocity 15ml/min, sample size 5ml;Carry out gradient by table 1 to wash It is de-,
Table 1 gradient elution table
Collecting ginsenoside Rg1, the eluent of Re respectively, eluent first low-temperature reduced-pressure below 50 DEG C reclaims acetonitrile, rear 60-80 DEG C high-temperature pressure-reduction concentrates, and concentrate vacuum freeze drying prepares freeze-dried powder.
2. the preparation method of a kind of ginsenoside Rg_1 and Re according to claim 1, it is characterised in that:Described ginseng stem Leaf total saposins is:Take gen-seng haulms, be cut into 1-2cm section, add boiling water twice, 2 hours for the first time, 1.5 hours for the second time, decoct Liquid filters, merging filtrate, and by D101 type large pore resin absorption column, water elution is extremely colourless, then uses 60% ethanol elution, collects 60% ethanol eluate, surveys the clear cream that relative density is 1.06-1.08, dry, pulverize, to obtain final product when filtrate is concentrated into 80 DEG C.
3. the preparation method of a kind of ginsenoside Rg_1 and Re according to claim 1, it is characterised in that:Described ginseng is total Saponin(e is:Taking ginseng, being cut into sheet, add boiling water twice, 2 hours for the first time, 1.5 hours for the second time, decoction liquor filtered, and merged Filtrate, by D101 type large pore resin absorption column, water elution is extremely colourless, then uses 60% ethanol elution, collects 60% ethanol elution Liquid, surveys the clear cream that relative density is 1.06-1.08, dry, pulverize, to obtain final product when filtrate is concentrated into 80 DEG C.
CN201610792895.6A 2016-08-31 2016-08-31 Preparation method of ginsenoside Rg1 and ginsenoside Re Pending CN106432392A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610792895.6A CN106432392A (en) 2016-08-31 2016-08-31 Preparation method of ginsenoside Rg1 and ginsenoside Re

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610792895.6A CN106432392A (en) 2016-08-31 2016-08-31 Preparation method of ginsenoside Rg1 and ginsenoside Re

Publications (1)

Publication Number Publication Date
CN106432392A true CN106432392A (en) 2017-02-22

Family

ID=58163960

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610792895.6A Pending CN106432392A (en) 2016-08-31 2016-08-31 Preparation method of ginsenoside Rg1 and ginsenoside Re

Country Status (1)

Country Link
CN (1) CN106432392A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108619200A (en) * 2018-07-11 2018-10-09 山西省芮城县红宝兽药有限责任公司 General ginsenoside injection for animals

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102464693A (en) * 2010-11-05 2012-05-23 李慧 Ginsenoside Re extraction and separation method
CN104807905A (en) * 2015-05-04 2015-07-29 中国人民解放军第三七一医院 Method for determining contents of ginsenosides Rg1 and Re in Xinnaoning tablet
CN105801656A (en) * 2014-12-30 2016-07-27 广西梧州制药(集团)股份有限公司 Method for purifying Rg1, Re and Rb1 from Panax notoginsenosides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102464693A (en) * 2010-11-05 2012-05-23 李慧 Ginsenoside Re extraction and separation method
CN105801656A (en) * 2014-12-30 2016-07-27 广西梧州制药(集团)股份有限公司 Method for purifying Rg1, Re and Rb1 from Panax notoginsenosides
CN104807905A (en) * 2015-05-04 2015-07-29 中国人民解放军第三七一医院 Method for determining contents of ginsenosides Rg1 and Re in Xinnaoning tablet

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈波等: "人参皂苷Re、Rg1标准对照品的高效液相色谱制备研究", 《实用预防医学》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108619200A (en) * 2018-07-11 2018-10-09 山西省芮城县红宝兽药有限责任公司 General ginsenoside injection for animals

Similar Documents

Publication Publication Date Title
CN102276679B (en) Method for extracting high-purity tea saponin from oil-tea-cake by decompression boiling
CN104592341A (en) Method for extracting asiaticoside and madecassoside from centella
CN103588785B (en) The process for purification of a kind of Ginkgolide A and Ginkgolide B
CN104892687B (en) The method that high speed adverse current chromatogram isolates and purifies monomeric compound in Chinese mahonia leaf
CN104306428B (en) A method of the extraction purification gypenoside from gynostemma pentaphylla
CN102824394B (en) Method for synchronously extracting and separating icariin and icarisid II from herba epimedii
CN102233013A (en) Preparation method for total saponins of pulsatilla chinensis
CN106589020B (en) A method of extracting icariin from Herba Epimedii
CN102229638B (en) Method for extracting oleanolic acid from chaenomeles fruit and preparing oleanolic acid standard
CN109879919B (en) Method for separating and preparing three flavonoid glycosides from spina date seeds
CN110437059B (en) Method for extracting pachymic acid A and pachymic acid B from Poria peel
CN102180938A (en) Method for preparing capilliposide
CN104447633A (en) Preparation method of terpenoid
CN104370895B (en) A kind of preparation method of orientin and Lutonaretin
CN102060905A (en) Technology method for preparing sea cucumber saponin Holotoxin A1 comparison product by utilizing fresh sea cucumber processing waste liquid
CN109021046A (en) A method of extracting quercitin and mountain naphthalene glycosides simultaneously from Siraitia grosvenorii cauline leaf
CN106432392A (en) Preparation method of ginsenoside Rg1 and ginsenoside Re
CN104910216A (en) Separation method for obtaining a plurality of epimeddium flavones by preparative liquid chromatography
CN102432656B (en) Method for extracting and purifying cordycepin from Cordyceps militaris sporophore
CN104693249A (en) Method for simultaneously separating and preparing syringin and oleuropein from syringa oblate lindl.
CN106317160A (en) Tribulus terrestris saponin K extracting and separating method
CN101496845B (en) Hedyotis diffusa Willd. extract and method for separating and preparing the same
CN105294789B (en) A kind of preparation method of high-purity salidroside
CN102670935B (en) Method for extracting total saponins from allium chinense
CN105906687B (en) A kind of method that a variety of tanshinone monomer components are isolated and purified from the red sage root

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170222

WD01 Invention patent application deemed withdrawn after publication